{
    "Trajectory2": [
    {
      "question_id": 0,
      "question_type": "RAG",
      "question": "According to the knowledge base, what was the main purpose of this radiogenomic study?",
      "ground_truth": "The main purpose was to create a radiogenomic map linking CT image features and gene expression profiles generated by RNA sequencing for patients with non-small cell lung cancer (NSCLC)."
    },
    {
      "question_id": 1,
      "question_type": "RAG",
      "question": "According to the knowledge base, how many patients with NSCLC were included in the study cohort?",
      "ground_truth": "The study included 113 patients with NSCLC."
    },
    {
      "question_id": 2,
      "question_type": "TEXT2SQL",
      "question": "According to the database, What is the distribution of patients across different ethnicities?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT Ethnicity, COUNT(*) as Count FROM clinical_genomic GROUP BY Ethnicity;",
        "ground_truth_sql_context": "Table clinical_genomic: - Case_ID: VARCHAR(50) - Ethnicity: VARCHAR(50)",
        "ground_truth_query_result": "Caucasian: 92, Hispanic/Latino: 5, Native Hawaiian/Pacific Islander: 1, African-American: 3, Asian: 18",
        "ground_truth_answer": "The distribution of patients across different ethnicities is as follows: Caucasian: 92, Hispanic/Latino: 5, Native Hawaiian/Pacific Islander: 1, African-American: 3, Asian: 18. This shows that the majority of patients in the study are Caucasian."
      }
    },
    {
      "question_id": 3,
      "question_type": "CUSTOM",
      "question": "Can you compute the imaging biomarkers for these 2 patients with patient IDs of R01-083 and R01-040?",
      "ground_truth": ""
    },
    {
      "question_id": 4,
      "question_type": "CUSTOM",
      "question": "Can you compute the imaging biomarkers for the 2 patients with the lowest CD4 expression values?",
      "ground_truth": ""
    }
  ],
  "Trajectory3": [
    {
      "question_id": 0,
      "question_type": "RAG",
      "question": "According to the knowledge base, what are the two main types of lung cancer examined in this study?",
      "ground_truth": "The study examined adenocarcinoma and squamous cell carcinoma, which are types of non-small cell lung cancer (NSCLC)."
    },
    {
      "question_id": 1,
      "question_type": "TEXT2SQL",
      "question": "According to the database, how many patients have each type of lung cancer histology?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT Histology, COUNT(*) as patient_count FROM clinical_genomic GROUP BY Histology",
        "ground_truth_sql_context": "[{'table_name': 'clinical_genomic', 'columns': [('Case_ID', 'VARCHAR(50)'), ('LRIG1', 'FLOAT'), ('HPGD', 'FLOAT'), ('GDF15', 'FLOAT'), ('CDH2', 'FLOAT'), ('POSTN', 'FLOAT'), ('VCAN', 'FLOAT'), ('PDGFRA', 'FLOAT'), ('VCAM1', 'FLOAT'), ('CD44', 'FLOAT'), ('CD48', 'FLOAT'), ('CD4', 'FLOAT'), ('LYL1', 'FLOAT'), ('SPI1', 'FLOAT'), ('CD37', 'FLOAT'), ('VIM', 'FLOAT'), ('LMO2', 'FLOAT'), ('EGR2', 'FLOAT'), ('BGN', 'FLOAT'), ('COL4A1', 'FLOAT'), ('COL5A1', 'FLOAT'), ('COL5A2', 'FLOAT'), ('Patient_affiliation', 'VARCHAR(50)'), ('Age_at_Histological_Diagnosis', 'INT'), ('Weight_lbs', 'FLOAT'), ('Gender', 'VARCHAR(10)'), ('Ethnicity', 'VARCHAR(50)'), ('Smoking_status', 'VARCHAR(50)'), ('Pack_Years', 'INT'), ('Histology', 'VARCHAR(70)'), ('Pathological_T_stage', 'VARCHAR(20)'), ('Pathological_N_stage', 'VARCHAR(20)'), ('Pathological_M_stage', 'VARCHAR(20)'), ('Histopathological_Grade', 'VARCHAR(70)'), ('Lymphovascular_invasion', 'VARCHAR(60)'), ('Pleural_invasion', 'VARCHAR(50)'), ('EGFR_mutation_status', 'VARCHAR(50)'), ('KRAS_mutation_status', 'VARCHAR(50)'), ('ALK_translocation_status', 'VARCHAR(50)'), ('Adjuvant_Treatment', 'VARCHAR(20)'), ('Chemotherapy', 'VARCHAR(20)'), ('Radiation', 'VARCHAR(20)'), ('Recurrence', 'VARCHAR(20)'), ('Recurrence_Location', 'VARCHAR(50)'), ('Survival_Status', 'BOOLEAN'), ('Survival_Duration', 'FLOAT')]}, {'table_name': 'chemotherapy_survival', 'columns': [('LRIG1', 'FLOAT'), ('Survival_Status', 'BOOLEAN'), ('Survival_Duration', 'FLOAT'), ('ExpressionGroup', 'FLOAT')]}]",
        "ground_truth_query_result": "[{'Histology': 'Adenocarcinoma', 'patient_count': 88}, {'Histology': 'Squamous cell carcinoma', 'patient_count': 28}, {'Histology': 'NSCLC NOS (not otherwise specified)', 'patient_count': 3}]",
        "ground_truth_answer": "There are 88 patients with adenocarcinoma, 28 with squamous cell carcinoma, and 3 with other types of NSCLC."
      }
    },
    {
      "question_id": 2,
      "question_type": "CUSTOM",
      "question": "Can you compute the imaging biomarkers for the 2 patients with the lowest gdf15 expression values and then highlight the elongation and sphericity of the tumor with these patients?",
      "ground_truth": ""
    }
  ],
  "Trajectory7": [
    {
      "question_id": 0,
      "question_type": "RAG",
      "question": "According to the knowledge base, what treatments were tracked for patients in this study?",
      "ground_truth": "The study tracked whether patients received adjuvant treatment, chemotherapy, and radiation therapy."
    },
    {
      "question_id": 1,
      "question_type": "TEXT2SQL",
      "question": "According to the database, How many patients received both chemotherapy and radiation?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT COUNT(*) FROM clinical_genomic WHERE Chemotherapy = 'Yes' AND Radiation = 'Yes';",
        "ground_truth_sql_context": "Table clinical_genomic: - Case_ID: VARCHAR(50) - Chemotherapy: VARCHAR(20) - Radiation: VARCHAR(20)",
        "ground_truth_query_result": "12",
        "ground_truth_answer": "The query results indicate that 12 patients received both chemotherapy and radiation treatment."
      }
    },
    {
      "question_id": 2,
      "question_type": "CUSTOM",
      "question": "What is the best gene biomarker (lowest p value) with overall survival for patients that have undergone chemotherapy?",
      "ground_truth": ""
    },
    {
      "question_id": 3,
      "question_type": "CUSTOM",
      "question": "Generate a bar chart of the top 5 gene biomarkers based on their p value and include their names in the x axis.",
      "ground_truth": ""
    }
  ],
  "Trajectory12": [
    {
      "question_id": 0,
      "question_type": "RAG",
      "question": "According to the knowledge base, how many highly coexpressed gene clusters (metagenes) were identified?",
      "ground_truth": "Ten highly coexpressed gene clusters, termed metagenes, were identified."
    },
    {
      "question_id": 1,
      "question_type": "TEXT2SQL",
      "question": "According to the database, What is the average expression value of the LRIG1 gene?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT AVG(LRIG1) FROM clinical_genomic;",
        "ground_truth_sql_context": "Table clinical_genomic: - Case_ID: VARCHAR(50) - LRIG1: FLOAT",
        "ground_truth_query_result": "22.3557",
        "ground_truth_answer": "The average expression value of the LRIG1 gene is 22.36."
      }
    },
    {
      "question_id": 2,
      "question_type": "CUSTOM",
      "question": "Show me a Kaplan-Meier chart for biomarker with name 'LRIG1' for chemotherapy patients by grouping expression values less than 10 and greater than or equal to 10"
    }
  ],
  "Trajectory16": [
    {
      "question_id": 0,
      "question_type": "RAG",
      "question": "According to the knowledge base, what did the study find about the late cell-cycle genes (metagene 38) and their association with CT imaging features?",
      "ground_truth": "The study found that metagene 38, which captures late cell-cycle genes, was significantly associated with nodule attenuation and margins. When this metagene was active, lesions tended to be solid. When inactive, lesions tended to have poorly defined margins."
    },
    {
      "question_id": 1,
      "question_type": "TEXT2SQL",
      "question": "According to the database, what is the survival duration for patients with different ground-glass opacity percentages?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT Percent_GG, AVG(Survival_Duration) as avg_survival, COUNT(*) as patient_count FROM clinical_genomic GROUP BY Percent_GG ORDER BY Percent_GG;",
        "ground_truth_sql_context": "Table clinical_genomic: - Case_ID: VARCHAR(50) - Survival_Duration: FLOAT - Percent_GG: VARCHAR(20)",
        "ground_truth_query_result": "[{'Percent_GG': '0%', 'avg_survival': 2.8, 'patient_count': 89}, {'Percent_GG': '1-25%', 'avg_survival': 3.2, 'patient_count': 12}, {'Percent_GG': '25-50%', 'avg_survival': 3.6, 'patient_count': 6}, {'Percent_GG': '50-75%', 'avg_survival': 4.1, 'patient_count': 4}, {'Percent_GG': '75-<100%', 'avg_survival': 4.3, 'patient_count': 1}, {'Percent_GG': '100%', 'avg_survival': 4.5, 'patient_count': 1}]",
        "ground_truth_answer": "The data shows that patients with higher ground-glass opacity percentages tend to have longer survival durations, with average survival increasing from 2.8 years for solid tumors to 4.5 years for pure ground-glass opacity tumors."
      }
    },
    {
      "question_id": 2,
      "question_type": "TEXT2SQL",
      "question": "According to the database, what percentage of patients with predominantly solid tumors (0-25% ground-glass) received chemotherapy compared to those with predominantly ground-glass tumors (>50%)?",
      "ground_truth": {
        "ground_truth_sql_query": "SELECT CASE WHEN Percent_GG IN ('0%', '1-25%') THEN 'Solid' WHEN Percent_GG IN ('50-75%', '75-<100%', '100%') THEN 'Ground-glass' END as tumor_type, COUNT(*) as total_patients, SUM(CASE WHEN Chemotherapy = 'Yes' THEN 1 ELSE 0 END) * 100.0 / COUNT(*) as chemo_percentage FROM clinical_genomic WHERE Percent_GG IN ('0%', '1-25%', '50-75%', '75-<100%', '100%') GROUP BY CASE WHEN Percent_GG IN ('0%', '1-25%') THEN 'Solid' WHEN Percent_GG IN ('50-75%', '75-<100%', '100%') THEN 'Ground-glass' END;",
        "ground_truth_sql_context": "Table clinical_genomic: - Case_ID: VARCHAR(50) - Percent_GG: VARCHAR(20) - Chemotherapy: VARCHAR(20)",
        "ground_truth_query_result": "[{'tumor_type': 'Solid', 'total_patients': 101, 'chemo_percentage': 42.6}, {'tumor_type': 'Ground-glass', 'total_patients': 6, 'chemo_percentage': 16.7}]",
        "ground_truth_answer": "42.6% of patients with predominantly solid tumors received chemotherapy, compared to only 16.7% of patients with predominantly ground-glass tumors, suggesting different treatment approaches based on tumor characteristics."
      }
    },
    {
      "question_id": 3,
      "question_type": "CUSTOM",
      "question": "Show me a Kaplan Meier chart for biomarker with name 'gdf15' for chemotherapy patients by grouping expression values less than 10 and greater than 10",
      "ground_truth": ""
    }
  ]
}